Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s):  AGNPF

Consumer Cyclical Healthcare Advertising Agencies Biotechnology
Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

Bullboard (CSE:AGN)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by StockHawk1on Mar 08, 2023 7:01pm

AGN holding SP gains

Algernon Pharmaceuticals Inc. (AGN.c AGNPF) closed stable today. Overall AGN has held most of the SP gains that it has made this week. Currently, the pharma-tech company is studying DMT for the ...more  
118
Post by stockpatrolon Mar 07, 2023 6:16pm

$AGN.c is making pace towards Phase 2 clinical trials of DMT

$AGN.c is making pace towards Phase 2 clinical trials of DMT treatment for TBI.    https://twitter.com/StocksNThoughts/status/1633207650715402241   The addition of r. David L ...more  
135
Post by SkywalkerofLukeon Mar 07, 2023 3:39pm

Recent News

AGN announced last week that its subsidiary Algernon NeuroScience appointed Dr. David L. Brody as a consultant for its clinical research program for the treatment of Traumatic Brain Injury with DMT.  ...more  
104
Comment by waves1on Mar 06, 2023 5:15pm

RE:AGN shoots up + yesterday's news

AGN is continuing a steady climb upwards with a 25% jump today; now up 50% the past 5 days!  Regarding the latest news, Dr. Brody is a solid addition to the team based on his unique clinical ...more  
47
Discussion
Post by EricSnotton Mar 05, 2023 6:05pm

Wow, sometimes you have to be good to be lucky or lucky to

be good...called it last week, but truly, AGN is heading back to the 30's...sorry to say!!!
110
Post by C10H12N2on Mar 05, 2023 6:01pm

Literally The Definition Of A Hail Mary News Release...

"Algernon NeuroScience Appoints Global TBI Expert and Former NFL Neurological Player Care Safety Director Dr. David Brody to Advisory Board"
163
Post by StockHawk1on Mar 03, 2023 6:37pm

AGN shoots up + yesterday's news

Algernon Pharmaceuticals Inc. (AGN.c AGNPF) closed up almost 32% on the CSE today.   Yesterday the pharma-tech company announced that the Global TBI Expert, Dr. David L. Brody will be a ...more  
227
Discussion
Comment by C10H12N2on Mar 03, 2023 9:24am

RE:RE:RE:100/1 Reverse Split Now Calculated As 25/1 Reverse Split.

Liquidity...yeah <that's the answer to all of Algernon Pharmaceuticals management ongoing destructive decisions.
62
Discussion
Post by StockHawk1on Mar 02, 2023 5:27pm

AGN appoints TBI expert for TBI-DMT study

Algernon Pharmaceuticals Inc. (AGN.c AGNPF) has appointed Global TBI Expert, Dr. David L. Brody as a consultant for its TBI-DMT clinical research program. Brody was a Professor of Neurology and ...more  
86
Post by Whalewatcher1on Mar 01, 2023 8:49pm

what a ss - 100/1 Reverse Split Now Calc As 25/1

i thought Chris was all about getting to Nasdaq, no chance of that happening any time soon. Then just filed on Feb 27 statement of executive compensation that board gives the CEO a $198K bonus, for ...more  
156
Post by StockHawk1on Mar 01, 2023 4:35pm

AGN CEO on Ifenprodil phase 2b study

Algernon Pharmaceuticals' (AGN.c AGNPF) CEO on AGN's Phase 2b Ifenprodi-Chronic Cough study. {^youtubevideo|(width)425|(height)264|(rel)False|(url)https://www.youtube.com/watch?v ...more  
143
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities